Evidence map›Paper›PMID 36130722›Full record

ArticleEuropean journal of cancer care2022

Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional survey.

Chantal Arditi, Manuela Eicher, Sara Colomer-Lahiguera, Christine Bienvenu, Sandro Anchisi, Daniel Betticher, Pierre-Yves Dietrich, Michel Duchosal, Solange Peters, Isabelle Peytremann-Bridevaux

Abstract readMulticenter Study
In one paragraph

Article in European journal of cancer care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Patient-centered AI.Frontiers in digital health · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chantal ArditiDepartment of Epidemiology and Health Systems, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-2799-8950
Manuela EicherInstitute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-7691-0719
Sara Colomer-LahigueraInstitute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-2390-5198
Christine BienvenuDepartment of Epidemiology and Health Systems, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Sandro AnchisiOncology Service, Hôpital du Valais - Hospital Center of Valais Romand (CHVR), Sion, Switzerland.
Daniel BetticherDepartment of Oncology, HFR Fribourg - Cantonal Hospital, Fribourg, Switzerland.
Pierre-Yves DietrichOncology Service, Geneva University Hospitals, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-7375-6939
Michel DuchosalDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Solange PetersDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Isabelle Peytremann-BridevauxDepartment of Epidemiology and Health Systems, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0002-6514-8781

Funding

Swiss Cancer Research Foundation HSR-4354-11-2017
6 · The paper itself

Abstract

objectivesThe objectives were to describe patients' experiences of cancer care in Switzerland and explore the variation of these experiences by type of cancer.

methodsThe Swiss Cancer Patient Experiences (SCAPE) study was a cross-sectional, multicentre survey conducted in 2018. Adult patients (n = 7145) with breast, prostate, lung, colorectal, skin or haematological cancer from four large hospitals in French-speaking Switzerland were invited to complete a survey. Logistic regressions were used to assess whether experiences varied according to cancer type, adjusting for confounders.

resultsOf the 3121 persons who returned the survey (44% response rate), 2755 reporting an eligible cancer were included in the analyses. Participants' average score for overall care was 8.5 out of a maximum score of 10. Higher rates of positive experiences were found for nurse consultations (94%), diagnostic tests (85%) and inpatient care (82%). Lower positive responses were reported for support for people with cancer (70%), treatment decisions (66%), diagnosis (65%) and home care (55%). We observed non-systematic differences in experiences of care by cancer type.

conclusionsThis large study identified that cancer patient experiences can be improved in relation to communication, information and supportive care aspects. Improvement efforts should target these areas of care to enhance responsiveness of cancer care.

Indexed as

NeoplasmsPatient SatisfactionAdultCommunicationCross-Sectional StudiesHospitalsHumansMaleSwitzerlandcancerpatient experiencespatient satisfactionpatient surveyquality of careSwitzerland

Identifiers

PMID36130722
PMCPMC9787424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.